发明授权
- 专利标题： Combination drug
-
申请号： US17358933申请日： 2021-06-25
-
公开(公告)号： US11896579B2公开(公告)日： 2024-02-13
- 发明人: Hiroshi Sakamoto , Toshiyuki Tsukaguchi
- 申请人： Chugai Seiyaku Kabushiki Kaisha
- 申请人地址： JP Tokyo
- 专利权人： Chugai Seiyaku Kabushiki Kaisha
- 当前专利权人： Chugai Seiyaku Kabushiki Kaisha
- 当前专利权人地址： JP Tokyo
- 代理机构： Foley & Lardner LLP
- 优先权： JP 15007244 2015.01.16
- 分案原申请号： US15543033
- 主分类号： A61K31/404
- IPC分类号： A61K31/404 ; A61K45/06 ; A61K31/4545 ; A61K31/506 ; A61K31/5355 ; A61K39/395 ; A61K31/44
摘要：
The present invention relates to a drug that is for treating or preventing cancer, that is effective in the treatment of cancer, and that comprises a combination of an ALK inhibitor and a VEGF inhibitor. The present invention also relates to a method for treating or preventing cancer and a method for inhibiting tumor growth.
公开/授权文献
- US20210322380A1 COMBINATION DRUG 公开/授权日：2021-10-21
信息查询
IPC分类:
